BY Clayton R. Boldt, Ph.D.

Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) encompass a spectrum of diseases characterized by an overproduction of immature blood cells, resulting in a lack of healthy, mature blood cells in patients.

Unfortunately, the majority of patients with these diseases are not cured with currently available therapies, so MD Anderson’s MDS and AML Moon Shot™ team has committed to developing new treatment options...

Simona Colla, Ph.D., associate professor of Leukemia at MD Anderson

BY Clayton R. Boldt, Ph.D.

September is Ovarian Cancer Awareness Month, an annual time to bring attention to the impact of the disease. This year, more than 22,000 women...